Latest Articles

The table below lists outside diameter (OD) and wall thickness in inches for NPS 1/2" through 12", per ASME B36.19M, covering the four most-used stainless schedules.   NPS OD (in) SCH 5S (in) SCH 10S (in) SCH 40S (in) SCH 80S (in) 1/2" 0.840 0.065 0.083 0.109 0.147 3/4" 1.050 0.065 0.083 0.113 0.154 1" 1.315 0.065 0.109 0.113 0.179 1-1/4" 1.660 0.065 0.109 0.140 0.191 1-1/2" 1.900 0.065 0.109 0.145 0.200 2" 2.375 0.065 0.109 0.154 0.218 2-1/2" 2.875 0.083 0.120 0.203 0.276 3" 3.500 0.083 0.120 0.216 0.300 4" 4.500 0.083 0.120 0.237 0.337 5" 5.563 0.109 0.134 0.258 0.375 6" 6.625 0.109 0.134 0.280 0.432 8" 8.625 0.109 0.148 0.322 0.500 10" 10.750 0.134 0.165 0.365 0.500 12" 12.750 0.156 0.180 0.375 0.500 Data per ASME B36.19M. Three ranges diverge from the equivalent carbon-steel values under B36.10M: SCH 10S at NPS 14–22, SCH 40S at NPS 12, and SCH 80S at NPS 10 and 12 (visible in the 0. ... Continue reading →

The medical specialty bags industry is witnessing steady growth amid rising demand for customized, innovative packaging solutions across healthcare sectors. Increasing adoption of advanced materials and stringent regulatory standards are shaping the competitive landscape, driving market players to innovate continuously. This dynamic market is projected to expand significantly over the forecast period, fueled by evolving patient care requirements and increasing medical device usage globally.   Market Size and Overview   The Medical Specialty Bags Market is estimated to be valued at USD 11.3 Bn in 2026 and is expected to reach USD 14.7 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.    Continue reading →

The non viral transfection reagents market is witnessing significant evolution driven by advances in gene therapy, cell engineering, and molecular biology applications. Innovations in reagent formulations and increasing demand across pharmaceutical and biotech sectors underscore this sector’s expanding industry size. Market players are capitalizing on rising research activities and clinical trials that fuel the need for efficient, safe transfection solutions. Market Size and Overview The non-viral transfection reagents market is estimated to be valued at USD 745.4 Mn in 2025 and is expected to reach USD 1319.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2032. This market forecast reflects strong Non Viral Transfection Reagents Market Growth driven by expanding research in gene editing and therapeutic protein production. The market report highlights increasing demand in both academic research and industrial applications, reinforcing the ... Continue reading →

The medical electrodes market is witnessing significant advancements driven by increasing demand for diagnostic and therapeutic applications worldwide. Innovation in electrode materials and expanding clinical applications are shaping the market dynamics, contributing to sustained business growth and evolving industry trends. Market Size and Overview The global medical electrodes market is estimated to be valued at USD 1,256.1 Mn in 2026 and is expected to reach USD 1,732.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.   Continue reading →

The Clinical Trial Software Market is rapidly evolving, driven by increasing adoption of digital tools to streamline clinical research processes and enhance data accuracy. Industry share gains are fueled by advancements in technology and rising demand for efficient trial management solutions, positioning the market for significant business growth. This overview reflects the dynamic market segments and growth strategies shaping the future of clinical research. Market Size and Overview The clinical trial software market is estimated to be valued at USD 1.03 Bn in 2025 and is expected to reach USD 2.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.5% from 2025 to 2032. This Clinical Trial Software Market Growth is supported by increasing clinical trial complexities, regulatory demands, and the escalating need for real-time data analytics and compliance solutions. The rising market revenue and expanding industry size underscore the strong market opportunities and ... Continue reading →

Telemarketing remains an important part of sales for businesses that need direct conversations with prospects and customers. However, not every call serves the same purpose. Some calls are initiated by customers who already have a question or buying need, while others are initiated by sales teams to create new opportunities. Understanding inbound vs outbound sales helps sales leaders decide how to structure teams, allocate budgets, measure performance, and select the right technology. While both approaches rely on effective communication, their workflows, goals, and key performance indicators can be very different. What Is Inbound Telemarketing? Inbound telemarketing starts when a prospect or customer contacts a business. The person may be responding to an advertisement, requesting information, asking for support, or showing interest in a product. Typical inbound activities include: - Handling product or service inquiries - Responding to marketing-generated leads - Qualifying ... Continue reading →

The United States candy market continues to demonstrate resilient growth backed by evolving consumer preferences and innovations. This dynamic industry is witnessing significant market opportunities spurred by demographic changes and product diversification, positioning key market players to leverage strong business growth and expanding market scope. Market Size and Overview The United States Candy Market is estimated to be valued at USD 25.02 Bn in 2025 and is expected to reach USD 32.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.7% from 2025 to 2032. Rising consumer demand for premium confectionery alongside increasing seasonal and festive sales contributes substantially to the United States Candy Market Growth. The growing appeal for healthier and organic candy variants also broadens the market segments, complementing the traditional sugar-based confectionery products. Market Drivers - Health-Conscious Consumer Demand Driving Product Innovation: In 2025, the ... Continue reading →

The paper packaging industry is witnessing robust expansion driven by rising demand for sustainable and biodegradable packaging solutions across diverse sectors. Increasing consumer preference for eco-friendly materials and stringent environmental regulations are shaping the market dynamics, positioning paper packaging as a critical segment in global packaging industry trends. Market Size and Overview The global paper packaging market is estimated at USD 472.92 Bn in 2026 and is expected to record a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033, reaching USD 669.89 Bn by 2033.   Continue reading →

The marine lubricant market is steadily evolving with increasing demand driven by global shipping activities and stringent environmental regulations. Industry players are focusing on advanced formulations to enhance fuel efficiency and comply with IMO 2020 sulfur cap regulations, directly influencing market trends and business growth. Market Size and Overview The Marine Lubricant Market size is valued at USD 6.22 Bn in 2026 and is expected to reach USD 7.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 2.0% from 2026 to 2033. Continue reading →

The Psychedelic Drugs industry is witnessing significant advancements driven by growing clinical adoption and increasing research into mental health therapies. This expanding sector is reshaping pharmaceutical approaches and attracting substantial investments focused on innovation and therapeutic efficacy. Market Size and Overview The psychedelic drugs market is estimated to be valued at USD 3.12 Bn in 2025 and is expected to reach USD 8.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2032. This Psychedelic Drugs Market Forecast reflects increasing interest in psychedelic compounds for treating disorders such as depression, PTSD, and anxiety. Rising market revenue and growing industry size are driven by substantial clinical trials and regulatory progress across key regions, enhancing the market scope and unlocking new market segments. Market Drivers A key market driver is the accelerating investment in clinical trials and regulatory approvals for ... Continue reading →